Chronic Myeloid Leukemia (Naomi)
CML Highlights of ASH 2023 - Biological overview
Treating CML in Developing Countries
Perspectives on the Future of CML
CML Highlights of ASH 2023 - Clinical overview
Clinical trial updates in CML
Updates in CLL - 2023 Best of Hematology Conference
Chronic Myeloid Leukemia: Approaches to Optimizing Care in the Era of TKIs
Myeloproliferative Neoplasms (MPNs) - Myeloproliferative Disorders - CML, PV, ET, PMF
Regional Discussion Group - June 24 - Latin America: TFR vs Dose Reduction
Nisha Lagilo Re || IPDC আমাদের গান || Chanchal Chowdhury & Meher Afroz Shaon
Treatment of Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)
𝙀𝙇𝘼 𝙅𝙊𝙂𝘼 𝙉𝘼 𝙃𝙊𝙍𝘼 - 𝙈𝘾 𝙋𝙊𝙂𝘽𝘼 & 𝘿𝙅 𝙂𝙐𝙄𝙃 𝘿𝘼 𝙕𝙊 (𝙗𝙚𝙨𝙩 𝙫𝙚𝙧𝙨𝙞𝙤𝙣) | 𝙩𝙞𝙠𝙩𝙤𝙠 𝙧𝙚𝙢𝙞𝙭 𝙭 "𝙏𝙝𝙚 𝙆𝙞𝙣𝙜 𝙤𝙛 𝘾𝙪𝙧𝙨𝙚𝙨"
Disease characteristics impacting treatment decisions in CLL
Ph+ acute lymphoblastic lymphoma and the immune system in hematological neoplasms.
Taking the Targeted Option for Myelofibrosis